| 1 |
Metabolic engineering of an industrial polyoxin producer for the targeted overproduction of designer nucleoside antibiotics
Qi JZ, Liu J, Wan D, Cai YS, Wang YH, Li SY, Wu P, Feng X, Qiu GF, Yang SP, Chen WQ, Deng ZX
Biotechnology and Bioengineering, 112(9), 1865, 2015 |
| 2 |
Improvement of gougerotin and nikkomycin production by engineering their biosynthetic gene clusters
Du D, Zhu Y, Wei JH, Tian YQ, Niu G, Tan HR
Applied Microbiology and Biotechnology, 97(14), 6383, 2013 |
| 3 |
New Milliliter-Scale Stirred Tank Bioreactors for the Cultivation of Mycelium Forming Microorganisms
Hortsch R, Stratmann A, Weuster-Botz D
Biotechnology and Bioengineering, 106(3), 443, 2010 |
| 4 |
Reducing the variability of antibiotic production in Streptomyces by cultivation in 24-square deepwell plates
Siebenberg S, Bapat PM, Lantz AE, Gust B, Heide L
Journal of Bioscience and Bioengineering, 109(3), 230, 2010 |
| 5 |
SanM catalyzes the formation of 4-pyridyl-2-oxo-4-hydroxyisovalerate in nikkomycin biosynthesis by interacting with SanN
Ling HB, Wang GJ, Tian YQ, Liu G, Tan HR
Biochemical and Biophysical Research Communications, 361(1), 196, 2007 |
| 6 |
SanT, a bidomain protein, is essential for nikkomycin biosynthesis of Streptomyces ansochromogenes
Jia LH, Tian YQ, Tan HR
Biochemical and Biophysical Research Communications, 362(4), 1031, 2007 |
| 7 |
Enhanced production of nikkomycin X by over-expression of SanO, a non-ribosomal peptide synthetase in Streptomyces ansochromogenes
Wang GJ, Tan HR
Biotechnology Letters, 26(3), 229, 2004 |
| 8 |
Disruption of sabR affects nikkomycin biosynthesis and morphogenesis in Streptomyces ansochromogenes
Li WL, Liu G, Tan HR
Biotechnology Letters, 25(18), 1491, 2003 |
| 9 |
Importance of growth form on production of hybrid antibiotic by Streptomyces lividans TK21 by fed-batch and continuous fermentation
Sarra M, Perez-Pons JA, Godia F, Alvero CC
Applied Biochemistry and Biotechnology, 75(2-3), 235, 1998 |
| 10 |
Continuous Production of a Hybrid Antibiotic by Streptomyces-Lividans Tk21 Pellets in a 3-Phase Fluidized-Bed Bioreactor
Sarra M, Casas C, Godia F
Biotechnology and Bioengineering, 53(6), 601, 1997 |
